查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233085

2023-2030 年按類型（單克隆）、服務（抗體開發）、來源（小鼠）、應用、最終用途、地區、細分市場預測的定制抗體市場規模、份額和趨勢分析報告

Custom Antibody Market Size, Share & Trends Analysis Report By Type (Monoclonal), By Service (Antibody Development), By Source (Mice), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

定制抗體市場增長和趨勢

Grand View Research, Inc. 最新報告顯示，2023 年至 2030 年全球定制抗體市場規模將以 9.7% 的複合年增長率增長，2030 年將達到 3.017 億，預計將到達美國美元。

預計在預測期內市場將出現顯著增長。 這種增長歸因於生物技術初創企業增加用於開發創新產品的資金。 此外，新興市場對個性化診斷和治療的認識不斷提高也有助於定制抗體市場的增長。

公司增加投資以擴大抗體開發和生產服務預計將支持市場增長。 例如，Absolute Antibody Ltd. 已進入定制抗體測序、表達和工程服務領域。 2022 年 8 月，該公司宣布將通過增加更多實驗室空間和投資下一代測序、純化和表達等自動化技術來擴大其製造設施。 這種擴展有望改善重組抗體製造工作流程。

同樣，公司也在改進定制抗體的應用。 根據 2023 年 1 月發表的一篇文章，MilliporeSigma 計劃利用其 Cell Marque Tissue Diagnostics 技術開發新抗體。 兔多克隆抗體被定制用於檢測 ATRX，一種神經膠質瘤。 神經膠質瘤佔中樞神經系統腫瘤的 30%。 該抗體有望擴大我們在神經病理學領域的產品組合。

通過監管機構的撥款和公司提供的折扣服務對學術研究機構的財政支持預計將在預測期內促進定制抗體的發現和研究。 例如，Absolute antibody 提供 10% 的定制服務折扣，AltaBioscience 也提供類似的限時折扣。 此類折扣有望降低研究人員的總體生產成本。

然而，製造定制單克隆抗體的高成本預計將抑制定制抗體市場的增長。 平均估計成本約為 6,000 美元至 15,000 美元。 這種成本是各種初創企業和新興參與者進入市場的障礙。 然而，通過開發可靠的製造試劑和技術，可以避免初始成本並降低成本。

定制抗體市場報告亮點

  • 從類型上看，2022年單克隆抗體領域有望比多克隆抗體領域相對成熟，成為主導領域。 預計公司增加研發投資將支持定制抗體市場的增長。
  • 按服務劃分，到 2022 年，抗體開發領域將佔據定制抗體市場的大部分份額。 該服務領域參與者的數量和類型超過抗體生產和碎片化，這有助於增長。
  • 根據來源，鼠標細分市場預計在預測期內增長最快。 這是因為小鼠是廣泛使用的實驗動物，可以很容易地用於定制抗體的生成。
  • 按應用劃分，傳染病將成為 2022 年市場份額最大的主要細分市場，預計這一趨勢將在預測期內持續存在。 這種增長可歸因於發展中國家新出現的傳染病。
  • 按最終用途劃分，學術和研究部門預計將成為 2022 年增長最快、市場份額最大的部分。 這種增長是由政府和企業補貼和資金的增加推動的。
  • 北美在市場中具有強大的區域地位，2022 年佔總市場份額的 44.91%。 不斷上升的癌症發病率和高昂的研發成本促使公司在該地區開發產品。

內容

第一章調查方法及範圍

  • 信息採購
  • 信息或數據分析
  • 市場範圍和細分定義
  • 市場模型
    • 市場調查，按公司市場份額
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場前景
  • 市場趨勢和前景
  • 市場動態
    • 對定制診斷和治療的需求不斷增加
    • 玩家之間的協作和夥伴關係輕鬆
    • 監管機構的舉措增加
  • 市場製約因素分析
    • 生產成本高
  • 2022 年滲透率和增長前景圖
  • 商業環境分析
    • SWOT 分析；按因素（政治和法律、經濟和技術）
    • 波特的五力分析
  • COVID-19 影響分析

第 4 章業務分析類型

  • 定制抗體市場：變化分析
  • 單克隆抗體
  • 多克隆抗體
  • 重組抗體
  • 其他

第5章服務業務分析

  • 定制抗體市場：服務波動分析
  • 抗體開發
  • 抗體生產和純化
  • 抗體的片段化和標記

第6章來源業務分析

  • 定制抗體市場：來源差異分析
  • 鼠標
  • 兔子
  • 其他

第 7 章應用業務分析

  • 定制抗體市場：應用差異分析
  • 腫瘤學
  • 感染
  • 神經學
  • 幹細胞
  • 免疫學
  • 心血管疾病
  • 其他

第 8 章最終用戶業務分析

  • 定制抗體市場：最終用戶差異分析
  • 製藥和生物技術公司
  • 學術和研究機構
  • 首席風險官
  • 醫院和診所

第9章區域業務分析

  • 2022 年和 2030 年按地區劃分的定制抗體市場份額
  • 北美
    • SWOT 分析
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 歐洲
    • SWOT 分析
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 亞太地區
    • SWOT 分析
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 拉丁美洲
    • SWOT 分析
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 多邊環境協定
    • SWOT 分析
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景

第10章競爭格局

  • 參與公司概覽
    • Thermo Fisher Scientific Inc.
    • Creative Diagnostics
    • Abcam plc
    • Bio-Rad Laboratories, Inc
    • Kaneka Eurogentec S.A.
    • YenZym Antibodies, LLC.
    • Abmart
    • Labcorp Drug Development
    • LifeSpan BioSciences, Inc
    • GenScript
  • 財務業績
  • 參與公司分類
    • 市場領導者
    • 2022 年定制抗體市場份額分析
    • 戰略規劃
      • 分機
      • 得到
      • 協作
      • 推出產品/服務
      • 夥伴關係
      • 其他
Product Code: GVR-4-68040-030-3

Custom Antibody Market Growth & Trends:

The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during the forecast period. This growth is attributed to the increasing fundraising by biotech startups for developing innovative products. Additionally, rising awareness of personalized diagnostic and therapeutic treatments in emerging markets is also a contributing factor to the growth of the custom antibody market.

Increasing investment by the players to expand their services in the development and production of antibodies is likely to support the growth of the market. For instance, Absolute Antibody Ltd. is into the services of custom antibody sequencing, expression, and engineering. In August 2022, the company announced the expansion of its manufacturing facility by increasing the lab space and investing in automated technology such as next-generation sequencing, purification, and expression. The expansion is expected to improve the production workflow for recombinant antibodies.

Similarly, companies are also improving the application of custom antibodies. According to an article published in January 2023, MilliporeSigma is planning to develop new antibodies through its Cell Marque Tissue Diagnostics technology. The rabbit polyclonal antibody is customized to detect a type of glioma, ATRX. Gliomas account for 30% of tumors in the central nervous system. Through this antibody, the company is anticipated to expand its portfolio in neuropathology.

Monetary support to academic and research institutions through grants from regulatory bodies and discount offers on services by companies are anticipated to enhance custom antibody discovery and research during the forecast period. For instance, Absolute antibody offers 10% off on custom services, while a similar discount is also offered by AltaBioscience for a limited time period. The discounts are expected to reduce the overall cost of production for researchers.

However, the high cost of producing custom monoclonal antibodies is expected to restrain the growth of the custom antibody market. The average estimated cost is around USD 6,000 to 15,000. The cost acts as a market entry barrier for various startups and emerging players. However, the cost can be reduced by developing reliable production reagents and techniques to avoid the upfront cost.

Custom Antibody Market Report Highlights:

  • By type, the monoclonal antibody segment is considered to be a relatively more mature and dominant segment than polyclonal in 2022. The increasing R&D investment by companies is expected to support the growth of the custom antibody market
  • By service, the antibody development segment captured the majority of the custom antibody market share in 2022. The number and type of players in this service segment are greater than antibody production and fragmentation, which is contributing to the growth
  • By source, the mice segment is estimated to be the fastest-growing during the forecast period. This is because mice are widely available lab animals and can be easily used for custom antibody production
  • By application, infectious disease is considered the key segment with the largest market share in 2022, and this trend is likely to be maintained over the forecast period. This growth can be attributed to the emerging infectious diseases in developing countries
  • By end-users, the academic and research institutions segment is estimated to be the fastest-growing segment, with the largest market share in 2022. The growth is attributed to the increasing grants and financial assistance from governments and companies
  • North America has established a strong regional position in the market with 44.91% of the overall market share in 2022. The increasing incidence rate of cancer and high R&D expenditure are encouraging companies to undertake product development in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing demand for customized diagnostics and therapeutics
    • 3.4.2. Ease of collaboration and partnerships amongst players
    • 3.4.3. Increasing initiatives by the regulatory bodies
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of production
  • 3.6. Penetration and Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Custom Antibody Market: Type Movement Analysis
  • 4.2. Monoclonal Antibodies
    • 4.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
  • 4.3. Polyclonal Antibodies
    • 4.3.1. Polyclonal Antibodies Market, 2018 - 2030 (USD Million)
  • 4.4. Recombinant Antibodies
    • 4.4.1. Recombinant Antibodies Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Service Business Analysis

  • 5.1. Custom Antibody Market: Service Movement Analysis
  • 5.2. Antibody Development
    • 5.2.1. Antibody Development Market, 2018 - 2030 (USD Million)
  • 5.3. Antibody Production & Purification
    • 5.3.1. Antibody Production & Purification Market, 2018 - 2030 (USD Million)
  • 5.4. Antibody Fragmentation & Labelling
    • 5.4.1. Antibody Fragmentation & Labelling Market, 2018 - 2030 (USD Million)

Chapter 6. Source Business Analysis

  • 6.1. Custom Antibody Market: Source Movement Analysis
  • 6.2. Mice
    • 6.2.1. Mice Market, 2018 - 2030 (USD Million)
  • 6.3. Rabbit
    • 6.3.1. Rabbit Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Custom Antibody Market: Application Movement Analysis
  • 7.2. Oncology
    • 7.2.1. Oncology Market, 2018 - 2030 (USD Million)
  • 7.3. Infectious Diseases
    • 7.3.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 7.4. Neurology
    • 7.4.1. Neurology Market, 2018 - 2030 (USD Million)
  • 7.5. Stem cells
    • 7.5.1. Stem cells Market, 2018 - 2030 (USD Million)
  • 7.6. Immunology
    • 7.6.1. Immunology Market, 2018 - 2030 (USD Million)
  • 7.7. Cardiovascular Diseases
    • 7.7.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-user Business Analysis

  • 8.1. Custom Antibody Market: End-user Movement Analysis
  • 8.2. Pharmaceutical & Biotechnology Companies
    • 8.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.3. Academic & Research Institutes
    • 8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.4. CRO
    • 8.4.1. CRO Market, 2018 - 2030 (USD Million)
  • 8.5. Hospitals and Clinics
    • 8.5.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Custom Antibody Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. SWOT Analysis
    • 9.2.2. North America Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.2.3. U.S.
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. U.S. Custom Antibody Market, 2018 - 2030 (USD MILLION)
    • 9.2.4. Canada
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Prevalence
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Canada Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. SWOT Analysis
    • 9.3.2. Europe Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.4. UK
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. UK Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.5. France
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. France Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.6. Italy
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Italy Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.7. Spain
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Spain Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Denmark Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.9. Sweden
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Sweden Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.10. Norway
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Target Disease Prevalence
      • 9.3.10.3. Competitive Scenario
      • 9.3.10.4. Regulatory Framework
      • 9.3.10.5. Reimbursement Scenario
      • 9.3.10.6. Norway Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. SWOT Analysis
    • 9.4.2. Asia Pacific Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. Japan Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.4. China
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. China Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.5. India
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. India Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.7. Australia
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Australia Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.8. Thailand
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Thailand Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. SWOT Analysis
    • 9.5.2. Latin America Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.5.3. Brazil
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Brazil Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.5.4. Mexico
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Mexico Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.5.5. Argentina
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. Argentina Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. SWOT Analysis
    • 9.6.2. MEA Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.3. South Africa
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. South Africa Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.4. Saudi Arabia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. Saudi Arabia Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.5. UAE
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. UAE Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.6. Kuwait
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Target Disease Prevalence
      • 9.6.6.3. Competitive Scenario
      • 9.6.6.4. Regulatory Framework
      • 9.6.6.5. Reimbursement Scenario
      • 9.6.6.6. Kuwait Custom Antibody Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
    • 10.1.1. Thermo Fisher Scientific Inc.
    • 10.1.2. Creative Diagnostics
    • 10.1.3. Abcam plc
    • 10.1.4. Bio-Rad Laboratories, Inc
    • 10.1.5. Kaneka Eurogentec S.A.
    • 10.1.6. YenZym Antibodies, LLC.
    • 10.1.7. Abmart
    • 10.1.8. Labcorp Drug Development
    • 10.1.9. LifeSpan BioSciences, Inc
    • 10.1.10. GenScript
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Custom Antibody Market Share Analysis, 2022
    • 10.3.3. Strategy Mapping
      • 10.3.3.1. Expansion
      • 10.3.3.2. Acquisition
      • 10.3.3.3. Collaborations
      • 10.3.3.4. Product/Service Launch
      • 10.3.3.5. Partnerships
      • 10.3.3.6. Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 6 Global Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 8 Global Custom Antibody Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 12 North America Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 13 North America Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 North America Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 15 U.S. Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 17 U.S. Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 18 U.S. Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 20 Canada Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Canada Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 23 Canada Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Canada Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 25 Europe Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Europe Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 29 Europe Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 31 Germany Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Germany Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 34 Germany Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Germany Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 36 UK Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 UK Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 38 UK Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 39 UK Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 UK Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 41 France Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 France Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 France Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 44 France Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 France Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 46 Italy Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Italy Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 48 Italy Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 49 Italy Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Italy Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 51 Spain Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Spain Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Spain Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 54 Spain Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Spain Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 56 Denmark Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 Denmark Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Denmark Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 59 Denmark Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Denmark Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 61 Sweden Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Sweden Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 63 Sweden Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 64 Sweden Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Sweden Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 66 Norway Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Norway Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Norway Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 69 Norway Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Norway Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 77 China Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 China Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 79 China Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 80 China Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 China Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 82 Japan Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Japan Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 Japan Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 85 Japan Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 Japan Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 87 India Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 India Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 89 India Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 90 India Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 India Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 92 South Korea Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 South Korea Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 94 South Korea Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 95 South Korea Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Korea Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 97 Australia Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 98 Australia Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 99 Australia Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 100 Australia Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 101 Australia Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 102 Thailand Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 103 Thailand Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 104 Thailand Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 105 Thailand Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Thailand Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 107 Latin America Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Latin America Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 110 Latin America Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 111 Latin America Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 Latin America Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 113 Brazil Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Brazil Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 115 Brazil Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 116 Brazil Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 117 Brazil Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 118 Mexico Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 119 Mexico Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Mexico Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 121 Mexico Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 122 Mexico Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 123 Argentina Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 124 Argentina Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 125 Argentina Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 126 Argentina Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 134 South Africa Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 135 South Africa Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 136 South Africa Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 137 South Africa Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 138 South Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 144 UAE Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 145 UAE Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 146 UAE Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 147 UAE Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 148 UAE Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Custom Antibody Market, by End-user, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Custom Antibody Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Custom Antibody Market: Type Movement Analysis
  • Fig. 17 Global Custom Antibody Market, for Monoclonal antibodies, 2018 - 2030 (USD Million)
  • Fig. 18 Global Custom Antibody Market, for Polyclonal Antibodies, 2018 - 2030 (USD Million)
  • Fig. 19 Global Custom Antibody Market, for Recombinant Antibodies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Custom Antibody Market: Service Movement Analysis
  • Fig. 22 Global Custom Antibody Market, for Antibody development, 2018 - 2030 (USD Million)
  • Fig. 23 Global Custom Antibody Market, for Antibody production & Purification, 2018 - 2030 (USD Million)
  • Fig. 24 Global Custom Antibody Market, for Antibody Fragmentation & labelling, 2018 - 2030 (USD Million)
  • Fig. 25 Global Custom Antibody Market: Source Movement Analysis
  • Fig. 26 Global Custom Antibody Market, for Mice, 2018 - 2030 (USD Million)
  • Fig. 27 Global Custom Antibody Market, for Rabbit, 2018 - 2030 (USD Million)
  • Fig. 28 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Custom Antibody Market: Application Movement Analysis
  • Fig. 30 Global Custom Antibody Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 31 Global Custom Antibody Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 32 Global Custom Antibody Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Custom Antibody Market, for Stem cells, 2018 - 2030 (USD Million)
  • Fig. 34 Global Custom Antibody Market, for Immunology, 2018 - 2030 (USD Million)
  • Fig. 35 Global Custom Antibody Market, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
  • Fig. 36 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Global Custom Antibody Market: End-user Movement Analysis
  • Fig. 38 Global Custom Antibody Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 39 Global Custom Antibody Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 40 Global Custom Antibody Market, for CRO, 2018 - 2030 (USD Million)
  • Fig. 41 Global Custom Antibody Market, for Hospitals and Clinics, 2018 - 2030 (USD Million)
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 Regional Outlook, 2022 & 2030
  • Fig. 44 Global Custom Antibody Market: Region Movement Analysis
  • Fig. 45 North America Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 50 UK Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 51 France Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 59 China Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 60 India Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Custom Antibody Market, 2018 - 2030 (USD Million)